He is expected to sign an executive order next week to pursue the initiative.
While the plan is still being finalized, it mirrors Trump’s earlier efforts from 2018 and 2020, both of which faced legal and political challenges. The proposal may face strong opposition from the pharmaceutical industry and potential lawsuits.
Trump hinted at a major announcement, likely related to this plan, during a recent meeting with Canadian Prime Minister Mark Carney. The White House aims to implement the policy using existing executive authority, bypassing congressional gridlock.
